Clinical Trial Update: A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) [Phase 3]

View source ↗

Summary

Phase III clinical trial assessing immunogenicity and safety of a lyophilized human diploid cell rabies vaccine in humans; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) (Rabies vaccine, human diploid cell (HDCV))

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Rabies Prevention | Phase 3 | Status: ENROLLING_BY_INVITATION